CARLSBAD, Calif.,
iVOW's common stock will trade under the symbol 'IVOWD' for 20 trading
days beginning on
At a special meeting of stockholders held on
'The Board of Directors authorized the reverse stock split to assist our
efforts to maintain compliance with the continued listing requirements of the
Nasdaq Capital Market,' said
iVOW
Our business is focused exclusively on the disease state management of chronic and morbid obesity. We provide program management, operational consulting and clinical training services to physicians and hospitals involved in the medical and surgical treatment of morbidly obese patients. We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is www.ivow.com; information on our nutritional supplements for post-surgical gastric bypass patients may be found on www.vistavitamins.com. iVOW is the new corporate name of Vista Medical Technologies, Inc. iVOW is traded on the Nasdaq Capital Market under the stock symbol IVOW.
Forward Looking Statements
This news release may contain forward-looking statements concerning the
business and products of iVOW. Actual results may differ materially depending
on a number of risk factors, including, but not limited to the following: the
successful closing of the acquisition of Sound Health Solutions; the
successful integration of the SHS business; our ability to penetrate the
market for obesity surgery management services; customer acceptance of our
products and services; decisions by Medicare and carriers to provide coverage
for bariatric surgical procedures; uncertainties related to our healthcare
services business model; and our efforts to maintain compliance with the
continued listing requirements of the Nasdaq SmallCap Market. Other risks
inherent in our business are described in our Securities and Exchange
Commission filings, including our Annual Report on Form 10-K for the year
ended
FOR FURTHER INFORMATION
AT iVOW: AT FINANCIAL RELATIONS BOARD:
Michael H. Owens,MD,MPH,FACPE,CPE Tony Rossi
President & CEO Media Contact
mowens@ivow.com trossi@financialrelationsboard.com
(760) 603-9120 (310) 854-8317
SOURCE iVOW, Inc.




